Single-dose H5N1 vaccine safe and effective in adults and elderly
Thursday, February 25, 2010 - 23:14
in Health & Medicine
Researchers from Hungary and the UK have developed a single-dose H5N1 influenza vaccine that induces a protective level of immunity against infection in healthy adult and elderly volunteers. The vaccine is the first single-dose regimen to be tested in elderly subjects and it fulfills all European Union and U.S. licensing criteria offering a promising influenza A virus vaccine candidate.